Also familiar with Have confidence biosimilar medicines biosimilar medicines prescribing biosimilar (37%). (62%). medicines (49%). 5.3.2 Familiarity with biosimilar medicines As with biologics, familiarity with biosimilars was highest among specialists and lowest among GPs. Two in three specialists (66%) were familiar with biosimilar medicines or (either ‘very familiar’ compared with 57% of pharmacists and 25% of GPs. Familiarity with biosimilar medicines ‘familiar’), was lower than for biologic medicines for specialists and GPs, but the reverse was true for pharmacists (however this difference was not statistically significant). Figure 17: Familiarity with biosimilar medicines Q2. How familiar are you with biosimilar medicines? The figure below provides details of statistically significant sub-group differences. Figure 18: Familiarity with biosimilar medicines sub group differences – Specialists General Practitioners Community pharmacists Specialists 'very familiar' or GP's more likely to be 'very Pharmacists 'very familiar' 'familiar' with biosimilar familiar' or 'familiar' with or 'familiar' with biosimilar medicines (66%) were biosimilar medicines (25%) medicines (57%) were more likely to : were more likely to: more likely to: Have prescribed Also be familiar with Also be familiar with biosimilar medicines biologic medicines biologic medicines (81%) (61%) (92%) Were confident Have prescribed biologic Have dispensed prescribing biosimilar medicines (41%) biosimilar medicines medicines (79%) Have confidence (85%). Were confident prescribing biosimilar switching a patient from medicines (41%) a reference biologic to a Were confident biosimilar medicine switching (36%). (74%). Figure 19: Familiarity with biologic and biosimilar medicines - comparison Q1. How familiar are you with biologic medicines? Q2. How familiar are you with biosimilar medicines?
Also familiar with biosimilar medicines (62%). Have confidence prescribing biosimilar medicines (49%). biosimilar medicines (37%). 5.3.2 Familiarity with biosimilar medicines As with biologics, familiarity with biosimilars was highest among specialists and lowest among GPs. Two in three specialists (66%) were familiar with biosimilar medicines (either ‘very familiar’ or ‘familiar’), compared with 57% of pharmacists and 25% of GPs. Familiarity with biosimilar medicines was lower than for biologic medicines for specialists and GPs, but the reverse was true for pharmacists (however this difference was not statistically significant). Figure 17: Familiarity with biosimilar medicines Q2. How familiar are you with biosimilar medicines? The figure below provides details of statistically significant sub-group differences. Figure 18: Familiarity with biosimilar medicines – sub group differences Specialists General Practitioners Community pharmacists Specialists 'very familiar' or 'familiar' with biosimilar medicines (66%) were more likely to : Have prescribed biosimilar medicines (81%) Were confident prescribing biosimilar medicines (79%) Were confident switching a patient from a reference biologic to a biosimilar medicine (74%). GP's more likely to be 'very familiar' or 'familiar' with biosimilar medicines (25%) were more likely to: Also be familiar with biologic medicines (61%) Have prescribed biologic medicines (41%) Have confidence prescribing biosimilar medicines (41%) Were confident switching (36%). Pharmacists 'very familiar' or 'familiar' with biosimilar medicines (57%) were more likely to: Also be familiar with biologic medicines (92%) Have dispensed biosimilar medicines (85%). Figure 19: Familiarity with biologic and biosimilar medicines - comparison Q1. How familiar are you with biologic medicines? Q2. How familiar are you with biosimilar medicines?